Danish Rheumatology Database (DANBIO), Anti-RheumaticTherapy in Sweden/Swedish Rheumatology Quality (ARTIS/SRQ), Center for Rheumatology Research (ICEBIO), Finnish Register of Biological Treatment (ROB-FIN) & Norwegian Antirheumatic Drug Register (NOR-DMARD) 2022, ' One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis : Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses ', Arthritis Care and Research, vol. 74, no. 5, pp. 748-758 . https://doi.org/10.1002/acr.24523
Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP RMD Open, 6(3). BMJ Publishing Group RMD Open Michelsen, B, Lindström, U, Codreanu, C, Ciurea, A, Zavada, J, Loft, A G, Pombo-Suarez, M, Onen, F, Kvien, T K, Rotar, Z, Santos, M J, Iannone, F, Hokkanen, A-M, Gudbjornsson, B, Askling, J, Ionescu, R, Nissen, M J, Pavelka, K, Sanchez-Piedra, C, Akar, S, Sexton, J, Tomsic, M, Santos, H, Sebastiani, M, Österlund, J, Geirsson, A J, Macfarlane, G, van der Horst-Bruinsma, I, Georgiadis, S, Brahe, C H, Ørnbjerg, L M, Hetland, M L & Østergaard, M 2020, ' Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration ', RMD Open, vol. 6, no. 3 . https://doi.org/10.1136/rmdopen-2020-001280 Michelsen, B, Lindström, U, Codreanu, C, Ciurea, A, Zavada, J, Loft, A G, Pombo-Suarez, M, Onen, F, Kvien, T K, Rotar, Z, Santos, M J, Iannone, F, Hokkanen, A M, Gudbjornsson, B, Askling, J, Ionescu, R, Nissen, M J, Pavelka, K, Sanchez-Piedra, C, Akar, S, Sexton, J, Tomsic, M, Santos, H, Sebastiani, M, Österlund, J, Geirsson, A J, Macfarlane, G, van der Horst-Bruinsma, I, Georgiadis, S, Brahe, C H, Ørnbjerg, L M, Hetland, M L & Østergaard, M 2020, ' Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment : routine care data from 13 registries in the EuroSpA collaboration ', RMD Open, vol. 6, no. 3 . https://doi.org/10.1136/rmdopen-2020-001280 Michelsen, B, Lindström, U, Codreanu, C, Ciurea, A, Zavada, J, Loft, A G, Pombo-Suarez, M, Onen, F, Kvien, T K, Rotar, Z, Santos, M J, Iannone, F, Hokkanen, A M, Gudbjornsson, B, Askling, J, Ionescu, R, Nissen, M J, Pavelka, K, Sanchez-Piedra, C, Akar, S, Sexton, J, Tomsic, M, Santos, H, Sebastiani, M, Österlund, J, Geirsson, A J, Macfarlane, G, van der Horst-Bruinsma, I, Georgiadis, S, Brahe, C H, Ørnbjerg, L M, Hetland, M L & Østergaard, M 2020, ' Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment : routine care data from 13 registries in the EuroSpA collaboration ', RMD Open, vol. 6, no. 3, e001280 . https://doi.org/10.1136/rmdopen-2020-001280